Keros Therapeutics Inc. (KROS)
NASDAQ: KROS
· Real-Time Price · USD
13.63
0.07 (0.52%)
At close: Jun 16, 2025, 3:59 PM
13.65
0.11%
After-hours: Jun 16, 2025, 07:08 PM EDT
0.52% (1D)
| Bid | 13.31 |
| Market Cap | 553.79M |
| Revenue (ttm) | 214.71M |
| Net Income (ttm) | 4.21M |
| EPS (ttm) | -0.17 |
| PE Ratio (ttm) | -80.21 |
| Forward PE | -3.2 |
| Analyst | Hold |
| Ask | 14.2 |
| Volume | 488,460 |
| Avg. Volume (20D) | 983,365 |
| Open | 13.65 |
| Previous Close | 13.56 |
| Day's Range | 13.50 - 13.91 |
| 52-Week Range | 9.12 - 72.37 |
| Beta | 1.29 |
About KROS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KROS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KROS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+18.49%
Keros Therapeutics shares are trading higher. The ...
Unlock content with
Pro Subscription
5 months ago
-16.51%
Keros Therapeutics shares are trading lower after the company announced an update on its Phase 2 TROPOS trial and halted all dosing based on the ongoing safety review.
2 weeks ago · https://thefly.com
BofA says Keros cost reduction 'disappoints,' still sees reasons to like story04 Jun
